Cargando…

Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study

BACKGROUND: In response to DNA double-strand breaks, the histone protein H2AX becomes phosphorylated at its C-terminal serine 139 residue, referred to as γ-H2AX. Formation of γ-H2AX foci is associated with recruitment of p53-binding protein 1 (53BP1), a regulator of the cellular response to DNA doub...

Descripción completa

Detalles Bibliográficos
Autores principales: Rasche, Ludwig, Heiserich, Lisa, Behrens, Janina Ruth, Lenz, Klaus, Pfuhl, Catherina, Wakonig, Katharina, Gieß, René Markus, Freitag, Erik, Eberle, Caroline, Wuerfel, Jens, Dörr, Jan, Bauer, Peter, Bellmann-Strobl, Judith, Paul, Friedemann, Roggenbuck, Dirk, Ruprecht, Klemens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731473/
https://www.ncbi.nlm.nih.gov/pubmed/26820970
http://dx.doi.org/10.1371/journal.pone.0147968
_version_ 1782412548443734016
author Rasche, Ludwig
Heiserich, Lisa
Behrens, Janina Ruth
Lenz, Klaus
Pfuhl, Catherina
Wakonig, Katharina
Gieß, René Markus
Freitag, Erik
Eberle, Caroline
Wuerfel, Jens
Dörr, Jan
Bauer, Peter
Bellmann-Strobl, Judith
Paul, Friedemann
Roggenbuck, Dirk
Ruprecht, Klemens
author_facet Rasche, Ludwig
Heiserich, Lisa
Behrens, Janina Ruth
Lenz, Klaus
Pfuhl, Catherina
Wakonig, Katharina
Gieß, René Markus
Freitag, Erik
Eberle, Caroline
Wuerfel, Jens
Dörr, Jan
Bauer, Peter
Bellmann-Strobl, Judith
Paul, Friedemann
Roggenbuck, Dirk
Ruprecht, Klemens
author_sort Rasche, Ludwig
collection PubMed
description BACKGROUND: In response to DNA double-strand breaks, the histone protein H2AX becomes phosphorylated at its C-terminal serine 139 residue, referred to as γ-H2AX. Formation of γ-H2AX foci is associated with recruitment of p53-binding protein 1 (53BP1), a regulator of the cellular response to DNA double-strand breaks. γ-H2AX expression in peripheral blood mononuclear cells (PBMCs) was recently proposed as a diagnostic and disease activity marker for multiple sclerosis (MS). OBJECTIVE: To evaluate the significance of γ-H2AX and 53BP1 foci in PBMCs as diagnostic and disease activity markers in patients with clinically isolated syndrome (CIS) and early relapsing-remitting MS (RRMS) using automated γ-H2AX and 53BP1 foci detection. METHODS: Immunocytochemistry was performed on freshly isolated PBMCs of patients with CIS/early RRMS (n = 25) and healthy controls (n = 27) with γ-H2AX and 53BP1 specific antibodies. Nuclear γ-H2AX and 53BP1 foci were determined using a fully automated reading system, assessing the numbers of γ-H2AX and 53BP1 foci per total number of cells and the percentage of cells with foci. Patients underwent contrast enhanced 3 Tesla magnetic resonance imaging (MRI) and clinical examination including expanded disability status scale (EDSS) score. γ-H2AX and 53BP1 were also compared in previously frozen PBMCs of each 10 CIS/early RRMS patients with and without contrast enhancing lesions (CEL) and 10 healthy controls. RESULTS: The median (range) number of γ-H2AX (0.04 [0–0.5]) and 53BP1 (0.005 [0–0.2]) foci per cell in freshly isolated PBMCs across all study participants was low and similar to previously reported values of healthy individuals. For both, γ-H2AX and 53BP1, the cellular focus number as well as the percentage of positive cells did not differ between patients with CIS/RRMS and healthy controls. γ-H2AX and 53BP1 levels neither correlated with number nor volume of T2-weighted lesions on MRI, nor with the EDSS. Although γ-H2AX, but not 53BP1, levels were higher in previously frozen PBMCs of patients with than without CEL, γ-H2AX values of both groups overlapped and γ-H2AX did not correlate with the number or volume of CEL. CONCLUSION: γ-H2AX and 53BP1 foci do not seem to be promising diagnostic or disease activity biomarkers in patients with early MS. Lymphocytic DNA double-strand breaks are unlikely to play a major role in the pathophysiology of MS.
format Online
Article
Text
id pubmed-4731473
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-47314732016-02-04 Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study Rasche, Ludwig Heiserich, Lisa Behrens, Janina Ruth Lenz, Klaus Pfuhl, Catherina Wakonig, Katharina Gieß, René Markus Freitag, Erik Eberle, Caroline Wuerfel, Jens Dörr, Jan Bauer, Peter Bellmann-Strobl, Judith Paul, Friedemann Roggenbuck, Dirk Ruprecht, Klemens PLoS One Research Article BACKGROUND: In response to DNA double-strand breaks, the histone protein H2AX becomes phosphorylated at its C-terminal serine 139 residue, referred to as γ-H2AX. Formation of γ-H2AX foci is associated with recruitment of p53-binding protein 1 (53BP1), a regulator of the cellular response to DNA double-strand breaks. γ-H2AX expression in peripheral blood mononuclear cells (PBMCs) was recently proposed as a diagnostic and disease activity marker for multiple sclerosis (MS). OBJECTIVE: To evaluate the significance of γ-H2AX and 53BP1 foci in PBMCs as diagnostic and disease activity markers in patients with clinically isolated syndrome (CIS) and early relapsing-remitting MS (RRMS) using automated γ-H2AX and 53BP1 foci detection. METHODS: Immunocytochemistry was performed on freshly isolated PBMCs of patients with CIS/early RRMS (n = 25) and healthy controls (n = 27) with γ-H2AX and 53BP1 specific antibodies. Nuclear γ-H2AX and 53BP1 foci were determined using a fully automated reading system, assessing the numbers of γ-H2AX and 53BP1 foci per total number of cells and the percentage of cells with foci. Patients underwent contrast enhanced 3 Tesla magnetic resonance imaging (MRI) and clinical examination including expanded disability status scale (EDSS) score. γ-H2AX and 53BP1 were also compared in previously frozen PBMCs of each 10 CIS/early RRMS patients with and without contrast enhancing lesions (CEL) and 10 healthy controls. RESULTS: The median (range) number of γ-H2AX (0.04 [0–0.5]) and 53BP1 (0.005 [0–0.2]) foci per cell in freshly isolated PBMCs across all study participants was low and similar to previously reported values of healthy individuals. For both, γ-H2AX and 53BP1, the cellular focus number as well as the percentage of positive cells did not differ between patients with CIS/RRMS and healthy controls. γ-H2AX and 53BP1 levels neither correlated with number nor volume of T2-weighted lesions on MRI, nor with the EDSS. Although γ-H2AX, but not 53BP1, levels were higher in previously frozen PBMCs of patients with than without CEL, γ-H2AX values of both groups overlapped and γ-H2AX did not correlate with the number or volume of CEL. CONCLUSION: γ-H2AX and 53BP1 foci do not seem to be promising diagnostic or disease activity biomarkers in patients with early MS. Lymphocytic DNA double-strand breaks are unlikely to play a major role in the pathophysiology of MS. Public Library of Science 2016-01-28 /pmc/articles/PMC4731473/ /pubmed/26820970 http://dx.doi.org/10.1371/journal.pone.0147968 Text en © 2016 Rasche et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Rasche, Ludwig
Heiserich, Lisa
Behrens, Janina Ruth
Lenz, Klaus
Pfuhl, Catherina
Wakonig, Katharina
Gieß, René Markus
Freitag, Erik
Eberle, Caroline
Wuerfel, Jens
Dörr, Jan
Bauer, Peter
Bellmann-Strobl, Judith
Paul, Friedemann
Roggenbuck, Dirk
Ruprecht, Klemens
Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study
title Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study
title_full Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study
title_fullStr Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study
title_full_unstemmed Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study
title_short Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study
title_sort analysis of lymphocytic dna damage in early multiple sclerosis by automated gamma-h2ax and 53bp1 foci detection: a case control study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731473/
https://www.ncbi.nlm.nih.gov/pubmed/26820970
http://dx.doi.org/10.1371/journal.pone.0147968
work_keys_str_mv AT rascheludwig analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy
AT heiserichlisa analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy
AT behrensjaninaruth analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy
AT lenzklaus analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy
AT pfuhlcatherina analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy
AT wakonigkatharina analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy
AT gießrenemarkus analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy
AT freitagerik analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy
AT eberlecaroline analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy
AT wuerfeljens analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy
AT dorrjan analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy
AT bauerpeter analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy
AT bellmannstrobljudith analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy
AT paulfriedemann analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy
AT roggenbuckdirk analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy
AT ruprechtklemens analysisoflymphocyticdnadamageinearlymultiplesclerosisbyautomatedgammah2axand53bp1focidetectionacasecontrolstudy